All employees at Lilly France felt the recognition by the French government of the importance of the Fegersheim site for the French pharmaceutical industry. It was also the recognition of our efforts to attract high added value investments, as evidenced by the 90 million euros investment announced last August.
Minister Montebourg visited the insulin cartridges filling areas, watched the ground works of the future extension, met employees and had an interview with Marcel Lechanteur, President of Lilly France and Benelux, regarding strategic issues in the development of Lilly France. During this exchange, discussions focused on the importance of higher visibility, flexibility on employment and predictability of the political and economic environment.
For all the French employees at Lilly this day was a highlight and reinforced the sense of pride of being part of a dynamic group that invests in the future for patients.
Watch media coverage of the Fegersheim visit here.